NeuroSigma gets green light from FDA for ADHD wearable

NeuroSigma has received US Food and Drug Administration (FDA) approval for its second-generation Monarch external trigeminal nerve stimulation (eTNS) system to treat paediatric attention deficit hyperactivity disorder (ADHD).